Cantor Fitzgerald reaffirmed its Overweight rating on Surgery Partners (NASDAQ:SGRY) with a steady price target of $36.00. The stock, which has shown significant momentum with a 20% return over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback